Login / Signup

Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma.

Surbhi SidanaHitomi HosoyaAlexandria M JensenLawrence LiuAnmol GoyalVanna HovankyBita SahafSushma BharadwajTheresa LatchfordSally AraiSheryl LeahyMatthew G MeiLihua E BuddeLori S MufflyMatthew J FrankSaurabh DahiyaMyo HtutDavid Bernard MiklosMurali Janakiram
Published in: Blood cancer journal (2023)
Keyphrases
  • cell therapy
  • multiple myeloma
  • high dose
  • low dose
  • stem cells
  • mesenchymal stem cells
  • chronic lymphocytic leukemia